Immunogenicity of Novel H1N1 Vaccination Among HIV-Infected Compared to HIV-Uninfected Persons

Exclusion Criteria

• •Healthcare worker who is involved in direct patient care
• •Acute febrile illnesses within 30 days prior to H1N1 vaccination (e.g., pneumonia, influenza, ILI)
• •Diabetes type 1 or type 2
• •Systemic steroid or immunosuppressive medication use within 4 weeks of vaccination
• •Active diagnoses of a cancer (non-melanoma skin cancer allowed).
• •History of organ transplant
• •Chronic active hepatitis B or C
• •Active illicit drug use or alcohol abuse
• •Blood transfusion within the last year
• •Allergy to eggs
• •Previous significant adverse reaction (e.g., anaphylaxis) to the seasonal influenza vaccination
• •History of serious reactions to any prior vaccination (e.g., Guillain Barre Syndrome (GBS)).
• •Received another vaccination in the last 4 weeks (receipt of seasonal influenza vaccination is allowed)
• •Among females of childbearing potential, pregnant or within 6 weeks of being postpartum
• •History of ILI which was confirmed as an H1N1 infection